Track topics on Twitter Track topics that are important to you
A meta-analysis of FDA patient-reported outcomes showed significant improvement in night vision and driving after LASIK with three of the latest FDA-approved laser platforms. Patient satisfaction was high, and dry eye was mild and transient. The three platforms were the Star S4 IR excimer laser with iDesign Advanced WaveScan Studio system (Abbott Medical Optics, now Johnson & Johnson Vision), the Allegretto Wave Eye-Q laser system with Allegro Topolyzer topography system and T-CAT treatment planning software (Alcon), and the EC-5000 excimer laser system with Final Fit custom ablation treatment planning software (Nidek). Seven hundred eighteen eyes of 530 patients undergoing laser correction for myopia and astigmatism were included in the retrospective study.
Original Article: Latest LASIK platforms boost patient-reported outcomesNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...